Mélissa Pelletier

No ORCID on file · 3 papers in corpus
observational 2024
BMC endocrine disorders ·doi:10.1186/s12902-024-01567-8

BACKGROUND: A better understanding of adipose tissue (AT) dysfunction, which includes morphological and functional changes such as adipocyte hypertrophy as well as impaired adipogenesis, lipid storage/mobilization, endocrine and inflammator…

observational 2022
Adipocyte ·doi:10.1080/21623945.2022.2059902

Adipose tissue (AT) dysfunctions, such as adipocyte hypertrophy, macrophage infiltration and secretory adiposopathy (low plasma adiponectin/leptin, A/L, ratio), associate with metabolic disorders. However, no study has compared the relative…

other 2014
Adipocyte ·doi:10.4161/adip.29385

Subcutaneous adipose tissue expansion through adipogenesis is increasingly recognized as a major determinant of body fat distribution and obesity-related cardiometabolic alterations. Our objective was to assess whether adipogenic rates of c…